推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

[HTML] Interleukin-28B genotype testing to determine response to the combination of pegylated-interferon and ribavirin for the treatment of hepatitis C virus

[HTML] from nih.govCM Nguyen, M Mendes, S Tsunoda… - PLoS Currents, 2011 - ncbi.nlm.nih.gov
Hepatitis C virus (HCV) is a bloodborne infection that is one of the leading causes of liver
disease. If left untreated, HCV can lead to cirrhosis, hepatocellular carcinoma, and death. The
current standard of care for HCV is a combination of pegylated-interferon (peg-IFN) and ...
Cited by 1 - Related articles - All 2 versions

[PDF] … Resistance-Associated Variants Observed in Patients Infected With HCV Genotype 1A/1b When Treated With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin

[PDF] from ihepa.comCA Brass, RJ Barnard, JA Howe, RA Ogert… - Gastroenterology, 2011 - ihepa.com
... Genotype 1a/1b When Treated With Boceprevir Plus Peginterferon Alfa-2b/Ribavirin
CA Brass1*, RJO Barnard1, JA Howe1, RA Ogert1, R. Ralston2, N. Boparai1,M.
Burroughs1, V. Sniukiene1, P. Mendez1, and J. Albrecht1 ...
View as HTML - All 2 versions

US Multicenter Pilot Study of Daily Consensus Interferon (CIFN) Plus Ribavirin for “Difficult-to-Treat” HCV Genotype 1 Patients

[HTML] from nih.govSB Ho, B Aqel, E Dieperink, S Liu, L Tetrick… - Digestive diseases and …, 2011 - Springer
(CIFN) Plus Ribavirin for ''Difficult-to-Treat'' HCV Genotype 1 ... Samuel B. Ho • Bashar Aqel •
Eric Dieperink • Shanglei Liu • Lori Tetrick • Yngve Falck-Ytter • Charles DeComarmond • Coleman
I. Smith • Daniel P. McKee • William Boyd • Clark C. Kulig • Edmund J. Bini • Marcos C. ...
Cited by 1 - Related articles - All 6 versions

[PDF] First SVR data with the nucleoside analogue polymerase inhibitor mericitabine (RG-7128) combined with peginterferon/ribavirin in treatment-naïve HCV G1/4 …

[PDF] from viraled.comP Pockros, D Jensen, N Tsai, RM Taylor… - 46th EASL Annual …, 2011 - viraled.com
P. Pockros, D. Jensen, N. Tsai, RM Taylor, A. Ramji, CL Cooper, R. Dickson, A. Tice, S.
Stancic, D. Ipe, I. Najera, JA Thommes, JM Vierling ... 46th EASL Congress, Berlin, Germany
March 30-April 3, 2011 Abstract 1359 ... • Mericitabine (RG7128, MCB) is a potent, ...
Cited by 3 - Related articles - View as HTML

Changes in Depressive Symptoms and Impact on Treatment Course Among Hepatitis C Patients Undergoing Interferon-α and Ribavirin Therapy: A Prospective …

J Chapman, M Oser, J Hockemeyer… - The American Journal …, 2011 - nature.com
The average depression score of the participants prior to commencing treatment was 7.4 (minimal
depression). Depressive symptoms increased over the course of treatment, with average scores
of 12.6 (mild depression) at the final assessment at the end of treatment. Patients with ...

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

增值电信业务经营许可证：沪B2-20211595

礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451